HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control

The CRISPR/Cas9 enabled efficient gene editing in an easy and programmable manner. Controlling its activity in greater precision is desired for biomedical research and potential therapeutic translation. Here, we engrafted the CRISPR/Cas9 system with a mutated human estrogen receptor (ERT2), which renders it 4-hydroxytamoxifen (4-OHT) inducible for the access of genome, and a nuclear export signal (NES), which lowers the background activity. Tight and efficient drug-inducible genome editing was achieved across several human cell types, including embryonic stem cells (ESCs) and mesenchymal stem cells (MSCs), upon vigorous optimization. Optimized terminal device, which we named hybrid drug inducible CRISPR/Cas9 technology (HIT-Cas9), delivered advantageous performances over several existing designs. Such architecture was also successfully applied to an orthogonal Cas9. The HIT-Cas9 system developed in this study will find broad utility in controlled editing of potentially any genomic loci.

[1]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[2]  C. Branda,et al.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. , 2004, Developmental cell.

[3]  Benjamin L. Oakes,et al.  Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch , 2016, Nature Biotechnology.

[4]  P Chambon,et al.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. , 1999, Nucleic acids research.

[5]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[6]  Y. Ying,et al.  Multiple Chemical Inducible Tal Effectors for Genome Editing and Transcription Activation. , 2018, ACS chemical biology.

[7]  Meagan E. Sullender,et al.  Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation , 2014, Nature Biotechnology.

[8]  Wendell A. Lim,et al.  Expanding the CRISPR imaging toolset with Staphylococcus aureus Cas9 for simultaneous imaging of multiple genomic loci , 2016, Nucleic acids research.

[9]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[10]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[11]  Jia Lu,et al.  Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing , 2017, Nucleic acids research.

[12]  Samuel H Sternberg,et al.  Rational design of a split-Cas9 enzyme complex , 2015, Proceedings of the National Academy of Sciences.

[13]  R. Campbell,et al.  Förster resonance energy transfer-based biosensors for multiparameter ratiometric imaging of Ca2+ dynamics and caspase-3 activity in single cells. , 2011, Analytical chemistry.

[14]  David J. Rawlings,et al.  Tracking genome engineering outcome at individual DNA breakpoints , 2011, Nature Methods.

[15]  C. Cepko,et al.  Controlled expression of transgenes introduced by in vivo electroporation , 2007, Proceedings of the National Academy of Sciences.

[16]  Alan Trounson,et al.  Stem Cell Therapies in Clinical Trials: Progress and Challenges. , 2015, Cell stem cell.

[17]  Jacob E Corn,et al.  Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA , 2016, Nature Biotechnology.

[18]  Feng Zhang,et al.  A split-Cas9 architecture for inducible genome editing and transcription modulation , 2015, Nature Biotechnology.

[19]  D. Segal,et al.  The generation of zinc finger proteins by modular assembly. , 2010, Methods in molecular biology.

[20]  J. Galipeau,et al.  Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. , 2018, Cell stem cell.

[21]  R. Tjian,et al.  Dynamics of CRISPR-Cas9 genome interrogation in living cells , 2015, Science.

[22]  P Chambon,et al.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. , 1997, Biochemical and biophysical research communications.

[23]  Bruce R. Conklin,et al.  Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity , 2016, Nature Communications.

[24]  David R. Liu,et al.  Small Molecule-Triggered Cas9 Protein with Improved Genome-Editing Specificity , 2015, Nature chemical biology.

[25]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[26]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[27]  Zengrong Zhu,et al.  An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. , 2014, Cell stem cell.

[28]  P. Chambon,et al.  Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Lukas E Dow,et al.  Inducible in vivo genome editing with CRISPR/Cas9 , 2015, Nature Biotechnology.

[30]  G. Church,et al.  Cas9 as a versatile tool for engineering biology , 2013, Nature Methods.

[31]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[32]  W. Wurst,et al.  Reversible and tissue‐specific activation of MAP kinase signaling by tamoxifen in brafV637ERT2 mice , 2013, Genesis.

[33]  Meagan E. Sullender,et al.  Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.

[34]  Martin J. Aryee,et al.  Engineered CRISPR-Cas9 nucleases with altered PAM specificities , 2015, Nature.

[35]  Xiujun Zhang,et al.  A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing. , 2016, Nature chemical biology.

[36]  David A. Scott,et al.  In vivo genome editing using Staphylococcus aureus Cas9 , 2015, Nature.